The association between LYRM4-AS1 (LYRM4 Antisense RNA 1) and Combined Oxidative Phosphorylation Deficiency 19 is supported by expert-curated evidence, drawing on a single expert-curated source, which records pathogenic variants.
Sources1
Clinical variants2
Symptoms34
Compounds0
Trials0
Publications1
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.